LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 18.22 | 771.67 | 1679 | 1741 | 0.9642 | 0.9388 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 20.44 | 771.67 | 1828 | 1910 | 0.9566 | 0.9334 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 20.44 | 771.67 | 1826 | 1910 | 0.9556 | 0.9317 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 22.66 | 771.67 | 2003 | 2141 | 0.9353 | 0.9112 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 22.66 | 771.67 | 1993 | 2141 | 0.9307 | 0.9047 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.89 | 771.67 | 2235 | 2397 | 0.9321 | 0.9159 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 24.89 | 771.67 | 2213 | 2397 | 0.9230 | 0.9043 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 27.11 | 771.67 | 2452 | 2675 | 0.9166 | 0.9052 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 27.11 | 771.67 | 2487 | 2675 | 0.9297 | 0.9203 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 29.33 | 771.67 | 2682 | 2939 | 0.9124 | 0.9072 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 29.33 | 771.67 | 2765 | 2939 | 0.9407 | 0.9376 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 31.55 | 771.67 | 2943 | 3196 | 0.9206 | 0.9209 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 31.55 | 771.67 | 3012 | 3196 | 0.9422 | 0.9428 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 33.78 | 771.67 | 3168 | 3499 | 0.9052 | 0.9108 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 33.78 | 771.67 | 3227 | 3499 | 0.9221 | 0.9270 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 36.00 | 771.67 | 3432 | 3884 | 0.8835 | 0.8965 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 36.00 | 771.67 | 3528 | 3884 | 0.9082 | 0.9191 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 38.22 | 771.67 | 3756 | 4299 | 0.8736 | 0.8938 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 38.22 | 771.67 | 3853 | 4299 | 0.8961 | 0.9134 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 40.44 | 771.67 | 4039 | 4738 | 0.8524 | 0.8817 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 40.44 | 771.67 | 4284 | 4738 | 0.9041 | 0.9245 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 42.67 | 771.67 | 4456 | 5155 | 0.8643 | 0.8963 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 42.67 | 771.67 | 4610 | 5155 | 0.8942 | 0.9200 | MN20160304_L01 | D12 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 44.89 | 771.67 | 4806 | 5541 | 0.8673 | 0.9023 | MN20160304_L01 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 44.89 | 771.67 | 5002 | 5541 | 0.9026 | 0.9293 | MN20160304_L01 | D12 |